The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Compounds currently in clinical trials for mitochondrial disease are predominantly antioxidants (such as Idebenone, EPI-743 and RPI-103) and small molecules that stabilize organelle membrane architecture (Elampritide/SS31).
“Compounds currently in clinical trials are predominantly antioxidants (such as Idebenone, EPI-743 and RPI-103) and small molecules that have the capability of stabilizing the organelle membrane architecture (Elampritide/SS31) [178].”
From The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics (2022) · cites this paper as [178]
The Discussion (page not provided) reports that SS-31 preserved mitochondrial cristae membranes and prevented swelling in rats with renal ischemia, supporting the membrane-stabilization part of the claim. Our copy does not support the broader assertion that clinical-trial compounds are predominantly antioxidants, identify Idebenone, EPI-743 or RPI-103 as trial compounds, or establish trials for mitochondrial disease. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors
Kagan, V. E., Tyurin, V. A., Jiang, J., Tyurina, Y. Y., Ritov, V. B., Amoscato, A. A., Osipov, A. N., Belikova, N. A., Kapralov, A. A., Kini, V., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio727 · Cited by 1,256
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Self-citationZhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782
Self-citationTargeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury
Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., & Sammut, I. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3718com · Cited by 618
Powers, S. K., Hudson, M. B., Nelson, W. B., Talbert, E. E., Min, K., Szeto, H. H., Kavazis, A. N., & Smuder, A. J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182190b62 · Cited by 255
Zhao, K., Luo, G., Giannelli, S., & Szeto, H. H. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.08.022 · Cited by 251
Self-citationBasova, L. V., Kurnikov, I. V., Wang, L., Ritov, V. B., Belikova, N. A., Vlasova, I. I., Pacheco, A. A., Winnica, D. E., Peterson, J., Bayir, H., et al. (2007) · Biochemistry · doi:10.1021/bi061854k · Cited by 212
Potent mitochondria-targeted peptides reduce myocardial infarction in rats
Cho, J., Won, K., Wu, D., Soong, Y., Liu, S., Szeto, H. H., & Hong, M. K. (2007) · Coronary Artery Disease · doi:10.1097/01.mca.0000236285.71683.b6 · Cited by 144
Self-citationThomas, D. A., Stauffer, C., Zhao, K., Yang, H., Sharma, V. K., Szeto, H. H., & Suthanthiran, M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080825 · Cited by 84
Self-citationDegradation of phospholipids by oxidative stress—Exceptional significance of cardiolipin
Wiswedel, I., Gardemann, A., Storch, A., Peter, D., & Schild, L. (2010) · Free Radical Research · doi:10.3109/10715760903352841 · Cited by 69
Flagged first, then by citations
Research works printed but not linked: 51
- Bagshaw, 2005, Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study., Crit Care, 9, R700, 10.1186/cc3879 · DOI
- Bon, 2012, New strategies to optimize kidney recovery and preservation in transplantation., Nat Rev Nephrol, 8, 339, 10.1038/nrneph.2012.83 · DOI
- Chapman, 2005, Chronic renal allograft dysfunction., J Am Soc Nephrol, 16, 3015, 10.1681/ASN.2005050463 · DOI
- Atkinson, 2004, Mechanism of actin polymerization in cellular ATP depletion., J Biol Chem, 279, 5194, 10.1074/jbc.M306973200 · DOI
- Sharfuddin, 2011, Pathophysiology of ischemic acute kidney injury., Nat Rev Nephrol, 7, 189, 10.1038/nrneph.2011.16 · DOI
- Puri, 1975, Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion., Am J Cardiol, 36, 234, 10.1016/0002-9149(75)90532-9 · DOI
- Schmiedl, 1990, The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling. Correlations during the course of myocardial global ischaemia., Virchows Arch A Pathol Anat Histopathol, 416, 305, 10.1007/BF01605291 · DOI
- Halestrap, 2010, A pore way to die: The role of mitochondria in reperfusion injury and cardioprotection., Biochem Soc Trans, 38, 841, 10.1042/BST0380841 · DOI
- Szeto, 2011, Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury., J Am Soc Nephrol, 22, 1041, 10.1681/ASN.2010080808 · DOI
- Hall, 2011, Pores for thought: New strategies to re-energize stressed mitochondria in acute kidney injury., J Am Soc Nephrol, 22, 986, 10.1681/ASN.2011030309 · DOI
- Osman, 2011, Making heads or tails of phospholipids in mitochondria., J Cell Biol, 192, 7, 10.1083/jcb.201006159 · DOI
- Frey, 2000, The internal structure of mitochondria., Trends Biochem Sci, 25, 319, 10.1016/S0968-0004(00)01609-1 · DOI
- Zhang, 2002, Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane., J Biol Chem, 277, 43553, 10.1074/jbc.C200551200 · DOI
- Pfeiffer, 2003, Cardiolipin stabilizes respiratory chain supercomplexes., J Biol Chem, 278, 52873, 10.1074/jbc.M308366200 · DOI · Paper page
- Kiebish, 2012, Myocardial regulation of lipidomic flux by cardiolipin synthase: Setting the beat for bioenergetic efficiency., J Biol Chem, 287, 25086, 10.1074/jbc.M112.340521 · DOI
- Claypool, 2009, Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function., Biochim Biophys Acta, 1788, 2059, 10.1016/j.bbamem.2009.04.020 · DOI
- Lesnefsky, 2001, Ischemic injury to mitochondrial electron transport in the aging heart: Damage to the iron-sulfur protein subunit of electron transport complex III., Arch Biochem Biophys, 385, 117, 10.1006/abbi.2000.2066 · DOI · Paper page
- Lesnefsky, 2009, Enhanced modification of cardiolipin during ischemia in the aged heart., J Mol Cell Cardiol, 46, 1008, 10.1016/j.yjmcc.2009.03.007 · DOI
- Vogel, 2006, Dynamic subcompartmentalization of the mitochondrial inner membrane., J Cell Biol, 175, 237, 10.1083/jcb.200605138 · DOI
- Ott, 2007, Role of cardiolipin in cytochrome c release from mitochondria., Cell Death Differ, 14, 1243, 10.1038/sj.cdd.4402135 · DOI
- Petrosillo, 2004, Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: Role of cardiolipin., J Biol Chem, 279, 53103, 10.1074/jbc.M407500200 · DOI
- Petrosillo, 2006, Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: Induction of permeability transition and cytochrome c release., FEBS Lett, 580, 6311, 10.1016/j.febslet.2006.10.036 · DOI · Paper page
- Korytowski, 2011, Permeabilization of the mitochondrial outer membrane by Bax/truncated Bid (tBid) proteins as sensitized by cardiolipin hydroperoxide translocation: Mechanistic implications for the intrinsic pathway of oxidative apoptosis., J Biol Chem, 286, 26334, 10.1074/jbc.M110.188516 · DOI
- Belikova, 2006, Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes., Biochemistry, 45, 4998, 10.1021/bi0525573 · DOI · Paper page
- Cohen, 2002, Probing protein electrostatics with a synthetic fluorescent amino acid., Science, 296, 1700, 10.1126/science.1069346 · DOI
- Leventis, 2010, The distribution and function of phosphatidylserine in cellular membranes., Annu Rev Biophys, 39, 407, 10.1146/annurev.biophys.093008.131234 · DOI · Paper page
- Petit, 1992, 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria., Eur J Biochem, 209, 267, 10.1111/j.1432-1033.1992.tb17285.x · DOI
- Paradies, 2009, Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease., Cell Calcium, 45, 643, 10.1016/j.ceca.2009.03.012 · DOI
- Vladimirov, 2006, Mechanism of activation of cytochrome C peroxidase activity by cardiolipin., Biochemistry (Mosc, 71, 989, 10.1134/S0006297906090070 · DOI
- Sinibaldi, 2010, Extended cardiolipin anchorage to cytochrome c: A model for protein-mitochondrial membrane binding., J Biol Inorg Chem, 15, 689, 10.1007/s00775-010-0636-z · DOI
- Sinibaldi, 2008, Insights into cytochrome c-cardiolipin interaction. Role played by ionic strength., Biochemistry, 47, 6928, 10.1021/bi800048v · DOI
- Santucci, 1997, The Soret circular dichroism spectrum as a probe for the heme Fe(III)-Met(80) axial bond in horse cytochrome c., J Inorg Biochem, 68, 211, 10.1016/S0162-0134(97)00100-1 · DOI
- Zuk, 1998, Polarity, integrin, and extracellular matrix dynamics in the postischemic rat kidney., Am J Physiol, 275, C711, 10.1152/ajpcell.1998.275.3.C711 · DOI
- Schwartz, 1999, Ischemia activates actin depolymerizing factor: Role in proximal tubule microvillar actin alterations., Am J Physiol, 276, F544
- Cho, 2007, A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36., J Biol Chem, 282, 4634, 10.1074/jbc.M609388200 · DOI
- Kloner, 2012, Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide., J Am Heart Assoc, 1, e001644, 10.1161/JAHA.112.001644 · DOI
- Eirin, 2012, A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis., Hypertension, 60, 1242, 10.1161/HYPERTENSIONAHA.112.199919 · DOI
- Smith, 2012, Mitochondrial pharmacology., Trends Pharmacol Sci, 33, 341, 10.1016/j.tips.2012.03.010 · DOI
- Chen, 2008, Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria., Am J Physiol Cell Physiol, 294, C460, 10.1152/ajpcell.00211.2007 · DOI · Paper page
- Borisenko, 2008, Molecular design of new inhibitors of peroxidase activity of cytochrome c/cardiolipin complexes: Fluorescent oxadiazole-derivatized cardiolipin., Biochemistry, 47, 13699, 10.1021/bi801507s · DOI
- Kagan, 2009, Mitochondria-targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: A new strategy in anti-apoptotic drug discovery., Mol Nutr Food Res, 53, 104, 10.1002/mnfr.200700402 · DOI
- Atkinson, 2011, A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death., Nat Commun, 2, 497, 10.1038/ncomms1499 · DOI
- Ji, 2012, Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury., Nat Neurosci, 15, 1407, 10.1038/nn.3195 · DOI
- Lesnefsky, 2001, Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria., Am J Physiol Heart Circ Physiol, 280, H2770, 10.1152/ajpheart.2001.280.6.H2770 · DOI
- Paradies, 1999, Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion., Free Radic Biol Med, 27, 42, 10.1016/S0891-5849(99)00032-5 · DOI
- Lesnefsky, 2004, Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: Role of cardiolipin., Am J Physiol Heart Circ Physiol, 287, H258, 10.1152/ajpheart.00348.2003 · DOI
- Kaasik, 2007, Regulation of mitochondrial matrix volume., Am J Physiol Cell Physiol, 292, C157, 10.1152/ajpcell.00272.2006 · DOI
- Plotnikov, 2011, Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion., Biochim Biophys Acta, 1812, 77, 10.1016/j.bbadis.2010.09.008 · DOI
- Sloan, 2012, Mitochondrial permeability transition in the diabetic heart: Contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury., J Mol Cell Cardiol, 52, 1009, 10.1016/j.yjmcc.2012.02.009 · DOI
- Nitz, 2002, Enantioselective synthesis and application of the highly fluorescent and environment-sensitive amino acid 6-(2-dimethylaminonaphthoyl) alanine (DANA)., Chem Commun (Camb, 17, 1912, 10.1039/b205224e · DOI
- Chen, 2006, Syntheses of aladan and [ald6]ioloatin C and study on their fluorescent properties., Chin J Chem, 24, 1411, 10.1002/cjoc.200690264 · DOI
Cited by
Sorted by citations
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
Münzel, T., Gori, T., Keaney, J. F., Maack, C., & Daiber, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv305 · Cited by 394
Tang, C., Han, H., Yan, M., Zhu, S., Liu, J., Liu, Z., He, L., Tan, J., Liu, Y., Liu, H., et al. (2018) · Autophagy · doi:10.1080/15548627.2017.1405880 · Cited by 309
Obre, E., & Rossignol, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.12.008 · Cited by 137
Sanchez-Contreras, M., Sweetwyne, M. T., Tsantilas, K. A., Whitson, J. A., Campbell, M. D., Kohrn, B. F., Kim, H. J., Hipp, M. J., Fredrickson, J., Nguyen, M. M., et al. (2023) · eLife · doi:10.7554/elife.83395 · Cited by 71
Escribano-Lopez, I., Diaz-Morales, N., Iannantuoni, F., Lopez-Domenech, S., de Marañon, A. M., Abad-Jimenez, Z., Bañuls, C., Rovira-Llopis, S., Herance, J. R., Rocha, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34251-8 · Cited by 71
Advancements in therapeutic drugs targeting of senescence
Zhu, M., Meng, P., Ling, X., & Zhou, L. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320964125 · Cited by 68
Zhang, M., Zhao, H., Cai, J., Li, H., Wu, Q., Qiao, T., & Li, K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185688 · Cited by 45
Roshanravan, B., Liu, S. Z., Ali, A. S., Shankland, E. G., Goss, C., Amory, J. K., Robertson, H. T., Marcinek, D. J., & Conley, K. E. (2021) · PLOS ONE · doi:10.1371/journal.pone.0253849 · Cited by 38
Self-citationYeung, M. H. Y., Leung, K. L., Choi, L. Y., Yoo, J. S., Yung, S., So, P.-K., & Wong, C.-M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.777395 · Cited by 14
The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics
Saravanan, S., Lewis, C. J., Dixit, B., O’Connor, M. S., Stolzing, A., & Boominathan, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020490 · Cited by 13
Metadata
- Authors
- Birk, A. V., Liu, S., Soong, Y., Mills, W., Singh, P., Warren, J. D., Seshan, S. V., Pardee, J. D., & Szeto, H. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2013-08
- Volume
- 24
- Issue
- 8
- Pages
- 1250-1261
- ISSN
- 1046-6673
- Cited by
- 479
- References
- 10
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review